Short Answer: In Canada, you can make appearance‑only claims like cleanse, moisturize, smooth, or add shine. You cannot claim to treat, prevent, or correct a disease or alter body functions without moving into drug or natural health product (NHP) rules. Regulators judge your words by the general (net) impression, not just the literal text. Not sure about your copy? Work with an Canadian importer of cosmetic products for a clear path forward.
What Is A “Cosmetic Claim” In Canada?
A cosmetic claim describes non‑therapeutic benefits such as cleansing, perfuming, protecting (in the everyday sense), maintaining, or improving appearance for skin, hair, teeth, or nails. Health Canada classifies products at the cosmetic–drug interface by looking at representation (claims), composition, and level of action. The overall impression controls, even if a single sentence looks harmless.
This matters because one word can flip your regulatory pathway, shifting you from post‑market cosmetic notification to a pre‑market authorization as a drug or NHP, with very different evidence, labelling, and import requirements. If you’re writing pack copy or ads, assume regulators will read the label, web page, visuals, and testimonials together as one message.
Examples Of Cosmetic Versus Drug/NHP Representations
Cosmetic‑safe examples: “softens hands,” “reduces frizz,” “adds shine,” “fresh scent.” These describe feel, look, or sensory effects without implying therapy.
Drug/NHP examples: “treats acne,” “heals eczema,” “regrows hair,” or SPF/UV protection claims. For example, sunscreen benefits almost always require authorization under Health Canada’s primary or secondary sunscreen monographs.
Claims You Can Usually Make (With Smart Qualifiers)
Most appearance/sensory claims are fine when the product’s composition supports them and your marketing doesn’t imply therapy. Think hydrate, smooth, detangle, or “improves the look of dull skin.” Keep the phrasing anchored to appearance, texture, or fragrance rather than function inside the body.
“Free‑from” and ingredient statements can be useful, but avoid implying superior safety unless you can back it. Align wording with your INCI list and avoid creating contradictions between copy and the Cosmetic Ingredient Hotlist (restricted/prohibited substances and required cautions).
Substantiation Basics
Under the Competition Act, material claims must be truthful and not misleading in their general impression. For performance‑type statements, have adequate and proper test evidence on file, conducted before you publish the claim. Keep methods, protocols, and results in a substantiation file that matches the exact wording used in market.
Grey‑Zone Claims That Need Caution (And Stronger Evidence)
Terms such as “hypoallergenic,” “dermatologist‑tested,” “non‑comedogenic,” and “for sensitive skin” are common, but they can imply therapeutic benefit if you overreach. Use precise definitions, state the basis for your claim, and avoid implying treatment of a condition. Keep the data on file and ensure the rest of your pack doesn’t contradict it (for example, by listing a known allergen).
Environmental claims are under new scrutiny. Canada’s Competition Bureau released final guidance on environmental claims in 2025. Be specific, avoid vague terms like “eco‑friendly,” and make sure product or business‑level environmental claims are backed by appropriate testing or recognized methodologies, as the law now requires.
Practical Do/Don’t Examples
Do: “Biodegradable formula per [method], tested at [lab], report on file.” Tie the statement to a standard, scope, and test window.
Don’t: “Green” or “planet‑safe” without a defined basis. The Bureau evaluates the general impression, so visual cues and layout count too, not just the sentence itself.
Off‑Limits Or Reclassifying Claims (With Common Triggers)
Claims that treat, prevent, cure, or heal are typically non‑cosmetic. Acne therapy, dandruff treatment, gingivitis reduction, hair growth claims, and most SPF/UV benefits require authorization under drug or NHP pathways. If your marketing needs these claims, plan for the right monograph and license.
Ingredients can also push you out of cosmetic territory or force warnings. Screen every formula against Health Canada’s Hotlist and adapt claims and labels to any restrictions. Be especially careful with high‑peroxide oral whitening, retinoids, and leave‑on actives at higher levels.
Category Nuances
Antiperspirants: In Canada, antiperspirants are generally treated like cosmetics because they reduce normal sweating and odour; however, products positioned for hyperhidrosis or making stronger therapeutic claims may be classified differently. Your copy should stick to everyday perspiration control and avoid disease‑type positioning.
The Rules Behind The Words: Three Lenses Regulators Use
Health Canada (classification and labelling)
Classification revolves around representation, composition, and level of action. On labelling, ensure bilingual INCI lists and required warnings. New rules phase in fragrance allergen disclosure: 24 allergens by April 12, 2026, then the full expanded list for new products on August 1, 2026, and for all existing products by August 1, 2028.
Competition Bureau (truthfulness)
Your claims must not be false or misleading, judged by the general impression. Keep adequate and proper test evidence for material representations before you advertise. This has become especially important for environmental messaging.
Ingredient controls (Hotlist)
The Hotlist flags prohibited and restricted substances and may require warnings that constrain what you can claim. A label or ad that conflicts with Hotlist‑driven limits risks enforcement.
Quick Reference Table (What You Can Say)
| Claim Type | Examples | Cosmetic Status & Risk |
| Appearance / Sensory | “Moisturizes,” “adds shine,” “fresh scent” | Usually OK as cosmetic; low risk. Needs only basic performance substantiation. |
| Grey Zone | “Hypoallergenic,” “for sensitive skin,” “biodegradable,” “Made in Canada” | Sometimes allowed. Requires strong test data, precise wording, and origin proof. Medium risk. |
| Therapeutic | “Treats acne,” “SPF 30,” “regrows hair,” “heals eczema” | Not acceptable as cosmetic. Needs drug/NHP authorization. High risk. |
How To Write Compliant Cosmetic Claims (Step‑By‑Step)
Start with a simple goal: keep benefits squarely in the appearance lane, align them with your formula, and hold evidence that matches the wording. Then follow this sequence.
- Classify your product first. Use Health Canada’s cosmetic–drug interface guidance and check that no benefit crosses into therapy. This saves rewrites later.
- Screen ingredients against the Hotlist. Confirm no prohibited substances and note any restricted‑use levels or required warnings that could limit claims.
- Map claims into three buckets. Allowed, grey‑zone, and off‑limits. Rewrite grey‑zone lines to appearance‑only phrases and remove medical language.
- Build a substantiation file. Keep “adequate and proper” test data, literature, or methods tied to the exact claim language. Date the studies and keep protocols.
- Draft compliant bilingual labels. Align INCI, warnings, and any fragrance allergen disclosure that now phases in from April 12, 2026 onward.
- Plan your sunscreen or therapy claims properly. If you need SPF or acne/dandruff benefits, pivot to the appropriate primary or secondary sunscreen monograph (or other relevant monographs) and pursue DIN/NPN as needed.
- File the CNF on time. Manufacturers and importers must notify Health Canada within 10 days of first sale. CNF is a post‑market notification, not a pre‑market approval.
When To Escalate To Drug/NHP Pathways
If your brand promise depends on SPF/UV protection, acne therapy, antiseptic action, hair regrowth, or other therapeutic benefits, build the licensing path into your launch plan. That means choosing the correct monograph, aligning active ingredients, and preparing the evidence and labels required for a DIN or NPN. It adds time, but it’s the only defensible way to keep the claim.
Some hybrids can stay cosmetic with careful phrasing, but don’t push the line. The general impression test applies to ads, visuals, and context, so subtle hints toward therapy can still trigger reclassification. When in doubt, we’ll help you model the risk and rewrite the benefit ladder without losing consumer meaning.
Why Work With Progress Therapeutics
You want compliant claims that still sell. We’ve handled Canadian market access since 2012 and act as your importer of record for Health Canada‑regulated products. We manage classification, copy reviews, CNFs, and risk calls with a bias for clarity and speed.
Progress Therapeutics holds a Drug Establishment Licence (DEL) for the importation of prescription and OTC products, a Site Licence (SL) for natural health products, and an MDEL for medical devices. That infrastructure lets us advise across categories when your roadmap spans cosmetics and therapeutic claims. Because we import on your behalf, we’re pragmatic about what will pass scrutiny at the border and on the shelf. Learn more about our cosmetic importation services or contact us for a consultation.
FAQs
Yes, if you have adequate and proper test evidence that supports the exact claim as consumers will read it. That includes methodology fit, sample size, controls, and timing. Without solid data, “clinically proven” risks being misleading under the Competition Act’s civil provisions. Keep the full report on file before you publish.
No. Statements like “SPF 30” or “UV protection” generally move the product into the sunscreen category (primary or secondary), which requires authorization under Health Canada’s monographs. If SPF is central to your value proposition, plan for the DIN/NPN path and write claims that match the monograph language.
Deodorants mask odour and are cosmetics. Antiperspirants reduce normal sweating and are also generally treated as cosmetics in Canada; however, if your positioning drifts toward hyperhidrosis or therapy, classification can change. Keep claims in the everyday‑use lane and avoid promising treatment.
Yes, with care. Define what those terms mean in your context and hold test data that matches the exact words and the general impression. Avoid implying disease prevention or therapy, and make sure your ingredient list and warnings don’t contradict the claim.
Yes. Canada is phasing in mandatory fragrance allergen disclosure: 24 allergens on all products by April 12, 2026, then the full expanded list for new products on August 1, 2026, and for all existing products by August 1, 2028. Plan artwork and CNF data updates now.
Indirectly, yes. If an ingredient is restricted or requires warnings, your label and advertising must reflect those limits. The Hotlist is also a good early‑warning system that helps you avoid claims that conflict with safe use.
No. The Cosmetic Notification Form (CNF) is a post‑market filing that must be submitted within 10 days of first sale in Canada. It helps Health Canada monitor products; it does not approve your claims or guarantee your classification. You still need to ensure your representations are compliant.